GlassScriptPhysician profile
Phillip J Stephan
NPI 1053387399
$20,966.21
in general payments reported to CMS, 2019-2025
7 companies · $5,488 in 2025
The $5,488 reported for 2025 was more than what 93% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $144 · 2021: $191 · 2022: $276 · 2023: $412 · 2024: $190 · 2025: $5,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,372 · Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,371.89 |
| Food and Beverage | $717.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14,411.96 | 2019-2022 | |
| Integra Lifesciences Corporation | $5,444.82 | 2020-2025 | Gentrix, Durasorb Monofilament Mesh, Integra |
| Abbvie INC. | $654.95 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $333.05 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $51.10 | 2019-2020 | |
| Sientra, INC. | $39.65 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $30.68 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Stephan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.